https://www.selleckchem.com/products/hrs-4642.html
Primary, secondary and tertiary structures of biosimilar Fraven® manufactured at both sites were found to be highly similar to the reference Neupogen®. Product related substances and impurities were also highly similar to the reference. Comparability of GCSF receptor binding affinities of each product was shown using the K values of SPR analysis. In vitro cell proliferation similarity was also evaluated and proven by PLA. Based on the similarity assessment, despite being manufactured at two different production sites, biosimilar Fraven